399 related articles for article (PubMed ID: 34319169)
1. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture.
Oraby AK; Gardner CL; Needle RF; Kofahi HM; Everard KR; Taylor NGA; Rutihinda SG; Barry JP; Hirasawa K; Georghiou PE; Russell RS
Microbiol Spectr; 2021 Sep; 9(1):e0043921. PubMed ID: 34319169
[TBL] [Abstract][Full Text] [Related]
2. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
[TBL] [Abstract][Full Text] [Related]
3. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
4. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies.
Ramirez S; Bukh J
Antiviral Res; 2018 Oct; 158():264-287. PubMed ID: 30059723
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model.
Galli A; Mens H; Gottwein JM; Gerstoft J; Bukh J
Sci Rep; 2018 Mar; 8(1):4619. PubMed ID: 29545599
[TBL] [Abstract][Full Text] [Related]
7. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
8. Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
Qing J; Luo R; Wang Y; Nong J; Wu M; Shao Y; Tang R; Yu X; Yin Z; Sun Y
Antiviral Res; 2016 Feb; 126():43-54. PubMed ID: 26724382
[TBL] [Abstract][Full Text] [Related]
9. RacGTPase-activating protein 1 interacts with hepatitis C virus polymerase NS5B to regulate viral replication.
Wu MJ; Ke PY; Horng JT
Biochem Biophys Res Commun; 2014 Nov; 454(1):19-24. PubMed ID: 25305482
[TBL] [Abstract][Full Text] [Related]
10. Discovery and characterization of a novel HCV inhibitor targeting the late stage of HCV life cycle.
Park SB; Boyer A; Hu Z; Le D; Liang TJ
Antivir Ther; 2019; 24(5):371-381. PubMed ID: 30880685
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
[TBL] [Abstract][Full Text] [Related]
12. A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage.
Reddy BU; Mullick R; Kumar A; Sharma G; Bag P; Roy CL; Sudha G; Tandon H; Dave P; Shukla A; Srinivasan P; Nandhitha M; Srinivasan N; Das S
Antiviral Res; 2018 Feb; 150():47-59. PubMed ID: 29224736
[TBL] [Abstract][Full Text] [Related]
13. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
15. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
Campos GRF; Bittar C; Jardim ACG; Shimizu JF; Batista MN; Paganini ER; Assis LR; Bartlett C; Harris M; Bolzani VDS; Regasini LO; Rahal P
J Gen Virol; 2017 Jul; 98(7):1693-1701. PubMed ID: 28699869
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.
Wu JZ; Yao N; Walker M; Hong Z
Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
[TBL] [Abstract][Full Text] [Related]
19. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Guedj J; Neumann AU
J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
[TBL] [Abstract][Full Text] [Related]
20. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]